1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Market Dynamics 6.1 Drivers 6.1.1 High Stability and Chemical Properties for Efficient Drug Delivery 6.1.2 Rising Adoption of Targeted Therapeutics and Image-Guided Therapies 6.1.3 Increasing Burden of Chronic Diseases and Development of Vaccines 6.2 Restraints 6.2.1 High Manufacturing Expenses and Technical Difficulties 6.2.2 Less Availability of Surfactant and Cosurfactant for Nanoemulsion 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Application in Drug Class 7.1.1 Anesthetics 7.1.2 Antibiotics 7.1.3 Nonsteroidal anti-inflammatory drugs (NSAIDs) 7.1.4 Immunosuppressants 7.1.5 Steroids 7.1.6 Others 7.2 By Route of Administration 7.2.1 Oral 7.2.2 Parenteral 7.2.3 Others 7.3 By Distribution Channel 7.3.1 Hospital Chain 7.3.2 Retail Stores 7.3.3 E-commerce 7.4 By Geography 7.4.1 North America 7.4.1.1 US 7.4.1.2 Canada 7.4.1.3 Mexico 7.4.2 Europe 7.4.2.1 France 7.4.2.2 Germany 7.4.2.3 UK 7.4.2.4 Italy 7.4.2.5 Spain 7.4.2.6 Rest of Europe 7.4.3 Asia-Pacific 7.4.3.1 China 7.4.3.2 Japan 7.4.3.3 India 7.4.3.4 Australia 7.4.3.5 South Korea 7.4.3.6 Rest of Asia-Pacific 7.4.4 Middle East & Africa 7.4.4.1 GCC 7.4.4.2 South Africa 7.4.4.3 Rest of MEA 7.4.5 South America 7.4.5.1 Brazil 7.4.5.2 Argentina 7.4.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Allergan 9.2 Ascendia Pharmaceuticals 9.2 Covaris, Inc 9.4 Foamix Pharmaceuticals 9.5 Latitude Pharmaceuticals Inc 9.6 Microfluidics (IDEX Corporation) 9.7 Mitsubishi Tanabe Pharma 9.8 Santen Pharmaceutical Co., Ltd 9.9 Taiwan Liposome Company, Ltd. * List Not Exhaustive 10. Future of the Market

Allergan, Ascendia Pharmaceuticals, Covaris, Inc, Foamix Pharmaceuticals, Latitude Pharmaceuticals Inc, Taiwan Liposome Company, Ltd, among others